Not approved by the FDA for any therapeutic indication
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
This, along with your personalized tiered dosing, will help you Smart Transition to a New Normal
Tipo de evidencia: ECA en humanos | Observacional | Animal | In vitro | Regulatorio Mechanism of Action El BPC-157 promueve la cicatrizacin al estimular la angiognesis, mejorar la produccin de colgeno y regular las vas inflamatorias
These products are not intended for human dosing, injection, or ingestion
Tissue Repair: Examining its effects on wound healing and cell regeneration